CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
CervoMed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31+0.07 (+3.12%)
Close on Oct 19, 2026
- Market cap
- $23.66M
- P/E (TTM)
- –
- Dividend yield
- –
CervoMed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | CervoMed | Industry median |
|---|---|---|
| Market Cap | $34.93M | $164.85M |
| Enterprise Value | $10.03M | $87.06M |
| PS Ratio | 105.42 | 3.60 |
| PB Ratio | 1.52 | 2.03 |
| P/TBV Ratio | 1.52 | 2.31 |
Enterprise value
| Measure | CervoMed | Industry median |
|---|---|---|
| EV / Sales | 30.26 | 2.43 |
Income (trailing twelve months)
| Measure | CervoMed | Industry median |
|---|---|---|
| Revenue | $331.30K | $57.94M |
| Operating Income | -$31.16M | -$21.44M |
| Net Income | -$30.35M | -$22.46M |
| EBITDA | -$31.16M | -$16.91M |
| EPS (Diluted) | -$3.21 | -$0.83 |
Margins
| Measure | CervoMed | Industry median |
|---|---|---|
| Operating Margin | -9407.0% | -44.5% |
| Profit Margin | -9160.9% | -39.2% |
| EBITDA Margin | -9407.0% | -31.3% |
Returns
| Measure | CervoMed | Industry median |
|---|---|---|
| Return on Equity (ROE) | -107.6% | -53.1% |
| Return on Assets (ROA) | -94.7% | -41.0% |
Growth
| Measure | CervoMed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -95.7% | 6.01% |
Balance sheet
| Measure | CervoMed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $24.90M | $62.42M |
| Net Cash (Debt) | $24.90M | $15.68M |
| Net Cash Per Share | $1.65 | $0.66 |
| Equity (Book Value) | $22.96M | $48.79M |
| Book Value Per Share | $1.52 | $1.36 |
| Tangible Book Value | $22.96M | $23.06M |
Cash flow (trailing twelve months)
| Measure | CervoMed | Industry median |
|---|---|---|
| Operating Cash Flow | -$27.98M | -$12.35M |
Efficiency
| Measure | CervoMed | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
| Revenue Per Employee | $22.09K | $398.96K |
| Profits Per Employee | -$2.02M | -$703.34K |
| Employee Count | 15 | 74 |
Dividends and yields
| Measure | CervoMed | Industry median |
|---|---|---|
| Earnings Yield | -86.9% | -22.7% |
Shares
| Measure | CervoMed | Industry median |
|---|---|---|
| Shares Outstanding | 15,119,100 | 58,179,650 |
| Shares Change (YoY) | 8.41% | 11.1% |
| Shares Change (QoQ) | 46.1% | 0.54% |
| Float | 9,537,560 | 49,173,100 |
| Shares Held by Insiders | 36.9% | 11.6% |
| Shares Held by Institutions | 11.6% | 59.4% |
Scores
| Measure | CervoMed | Industry median |
|---|---|---|
| Altman Z-Score | -3.08 | -0.24 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from CervoMed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.